Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling

Oncogene

Volumn 26, Issue 18, 2007, Pages 2642-2648

  Barrier, A ^a,b,c,d   Roser, F ^b,e,f   Boelle P Y ^b,c   Franc, B ^g,h   Tse, C ^a,c   Brault, D ^a,c   Lacaine, F ^a,c   Houry, S ^a,c   Callard, P ^a,c   Penna, C ^g,h   Debuire, B ^b,e,f   Flahault, A ^b,c   Dudoit, S ^d   Lemoine, A ^b,e,f  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HÔPITAL PAUL BROUSSE   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g HÔPITAL AMBROISE PARÉ   (France)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

cDNA arrays; Colon cancer; Cross validation; Functional genomics; Non neoplastic mucosa; Prognosis prediction

Indexed keywords

MESSENGER RNA; PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLON CANCER; COLON MUCOSA; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; FEMALE; GENE; GENE EXPRESSION; GENECHIP; GENETIC CODE; HUMAN; IMMUNOSURVEILLANCE; MALE; METASTASIS; MICROARRAY ANALYSIS; MICROCHIP ANALYSIS; NUCLEOTIDE SEQUENCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SAMPLE; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; VALIDATION STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 34247392921     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210060     Document Type: Article

References (27)

1. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D et al. (1999). Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci 96: 6745-6750.
2. Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R et al. (2005). Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129: 874-884.
3. Barbier M, Attoub S, Calvez R, Laffargue M, Jarry A, Mareel M et al. (2001). Tumour biology. Weakening link to colorectal cancer? Nature 413: 796.
4. Barrier A, Boelle PY, Roser F, Gregg J, Tse C, Brault D et al. (2006). Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24: (in press).
5. Barrier A, Lemoine A, Boelle PY, Tse C, Brault D, Chiappini F et al. (2005). Colon cancer prognosis prediction by gene expression profiling. Oncogene 24: 6155-6164.
6. Benson III AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ et al. (2004). American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22: 3408-3419.
7. Bernards R, Weinberg RA. (2002). A progression puzzle. Nature 418: 823-824.
8. Bolstad BM, Irizarry RA, Gautier L, Wu Z. (2005). Bioinformatics and Computational Biology Solutions Using R and Bioconductor: Preprocessing High-density Oligonucleotide Arrays. Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S (eds). Springer: New York, NY. pp. 13-32.
9. Dudoit S, Fridlyand J. (2003). Classification in Microarray experiments. Statistical Analysis of Gene Expression Micro-Array Data. In: Speed T (ed). Chapman & Hall/CRC: Boca Raton, FL, pp. 93-158.
10. Dudoit S, Fridlyand J, Speed TP. (2002). Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Statist Assoc 97: 77-87.
11. Dudoit S, van der Laan MJ. (2005). Asymptotics of cross-validation risk estimation in estimator selection and performance assessment. Statist Methodol 2: 131-154.
12. Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. (2004). Adjuvant therapy for stage II colon cancer. A systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol 22: 3395-3407.
13. Hashida H, Takabayashi A, Tokuhara T, Hattori N, Taki T, Hasegawa H et al. (2003). Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer 89: 158-167.
14. Kanekura T, Chen X, Kanzaki T. (2002). Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 99: 520-528.
15. Kitahara O, Furukawa Y, Tanaka TC, Ono K, Yanagawa R, Nita ME et al. (2002). Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61: 3544-3549.
16. Kristiansen G, Sammar M, Altevogt P. (2004). Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35: 255-262.
17. Li O, Zheng P, Liu Y. (2004). CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host. J Exp Med 200: 1083-1089.
18. Mazzocca A, Carloni V, Sciammetta S, Cordella C, Pantaleo P, Caldini A et al. (2002). Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. J Hepatol 37: 322-330.
19. Mueller MM, Fusenig NE. (2004). Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849.
20. Michiels S, Koscielny S, Hill C. (2005). Prediction of cancer outcome with microarrays. A multiple random validation strategy. Lancet 365: 488-492.
21. Notterman DA, Alon U, Sierk AJ, Levine AJ. (2002). Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130.
22. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R et al. (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353: 2654-2666.
23. Ramaswamy S, Ross KN, Lander ES, Golub TR. (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54.
24. Schindelmann S, Windisch J, Grundmann R, Kreienberg R, Zeillinger R, Deissler H et al. (2002). Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24. Tumour Biol 23: 139-145.
25. Tanaka T, Akatsuka S, OzekiM, Shirase T, Hiai H, Toyokuni S et al. (2004). Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 23: 3980-3989.
26. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J et al. (2004). Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 27: 1564-1571.
27. Zou TT, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y et al. (2002). Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21: 4855-4862.